Bench Press: BioWorld looks at translational medicine
Monday, May 5, 2014
Two independent teams of scientists, one from the Chinese Tsinghua University and one from the Dana-Farber Cancer Institute and the University of North Carolina, have identified antibodies to the Middle Eastern Respiratory Syndrome coronavirus (MERS-CoV) that may form the basis of prophylactic or therapeutic treatments against the virus.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.